The efficacy and safety of omalizumab in refractory chronic spontaneous urticaria: real-life experience in Turkey

Bulur, Isil; BÜLBÜL BAŞKAN, EMEL; Ozdemir, Mustafa; Balevi, Ali; Goncu, Emek; Altunay, Ilknur; Gonul, Muzeyyen; Ergin, Can; ERTAM SAĞDUYU, İLGEN; ERDOĞAN, HİLAL; BİLGİN, MUZAFFER; Erdem, Mustafa

doi:10.15570/actaapa.2018.25

The efficacy and safety of omalizumab in refractory chronic spontaneous urticaria: real-life experience in Turkey

Bulur I., BÜLBÜL BAŞKAN E., Ozdemir M., Balevi A., Goncu E. K., Altunay I., ...More

ACTA DERMATOVENEROLOGICA ALPINA PANNONICA ET ADRIATICA, vol.27, no.3, pp.121-126, 2018 (ESCI, Scopus)

Publication Type: Article / Article
Volume: 27 Issue: 3
Publication Date: 2018
Doi Number: 10.15570/actaapa.2018.25
Journal Name: ACTA DERMATOVENEROLOGICA ALPINA PANNONICA ET ADRIATICA
Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus
Page Numbers: pp.121-126
Bursa Uludag University Affiliated: Yes

Abstract

Introduction: This study used real-world data to evaluate the effectiveness and reliability of omalizumab in treating recalcitrant chronic spontaneous urticaria in Turkish patients.